QLS12010 for moderate to severe hidradenitis suppurativa
Treatments studied
Part of Skin clinical trials.
This trial tests an experimental drug called QLS12010 for people with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with antibiotics. The goal is to see if this new treatment can help reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had hidradenitis suppurativa (HS) for at least 6 months.
- Your HS is moderate to severe right now.
- Antibiotics for HS have not worked for you, or you cannot take them due to side effects or other reasons.
- You do not have more than 20 open or closed tunnels (fistulas or sinus tracts) in your skin.
- You have no serious heart or blood vessel problems in the last 6 months (like a heart attack or stroke).
- You have not used a drug like QLS12010 before, or been in another clinical trial in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, QLS12010, to see if it is safe and how it works in healthy volunteers and in people with moderate to severe atopic dermatitis (eczema). It may offer a new treatment option for those whose eczema has not improved with topical creams.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This study tests a new drug called LAD328 for hidradenitis suppurativa (HS), a chronic skin condition with painful lumps and abscesses. The trial is looking for adults with moderate-to-severe HS who haven't responded well to antibiotics to see if this new treatment can help reduce symptoms.
This study tests a new medicine called LAD191 for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. Researchers want to see if LAD191 safely reduces painful bumps and tunnels.
This trial tests a new medication, SAR445399, for people with moderate to severe hidradenitis suppurativa (HS) who haven't improved with oral antibiotics. It aims to see if the drug safely reduces skin bumps and abscesses.
Hear when a new Adults With Moderate-to-severe Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.